<ul data-eligibleForWebStory="false"><li>Ajit Mishra, senior vice president of research at Religare Broking, recommended buying shares of Aurobindo Pharma Ltd. and LIC Housing Finance Ltd.</li><li>Mishra advised buying Aurobindo Pharma at the current market price with a stop loss of Rs 1,110 and a target of Rs 1,240, citing its various therapeutic segments and strong presence in domestic and international markets.</li><li>He also suggested LIC Housing Finance at the current market price with a stop loss of Rs 600 and a target of Rs 630, highlighting its provision of long-term finance for residential properties and robust loan portfolio.</li><li>The views expressed are those of the investment adviser and viewers are advised to consult their financial adviser before making any investment decisions.</li></ul>

Buy Or Sell: Aurobindo Pharma, LIC Housing Finance On Ajit Mishra's Radar — Check Target Price

Discover more